Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin-Sying Lin

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Transfusion|November 8, 2005
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patientsRichard J Benjamin, Jeffrey McCullough, Paul D Mintz, et al.
Transfusion|September 1, 2005
Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated setKarin Janetzko, Jean-Pierre Cazenave, Harald Klüter, et al.
Transfusion|September 28, 2006
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraPaul D Mintz, Anne Neff, Malcolm MacKenzie, et al.
Blood|May 13, 2004
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT TrialJeffrey McCullough, David H Vesole, Richard J Benjamin, et al.
Transfusion|June 24, 2022
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet componentsEdward L Snyder, Allison P Wheeler, Majed Refaai, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Transfusion|November 8, 2005
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patientsRichard J Benjamin, Jeffrey McCullough, Paul D Mintz, et al.
Transfusion|September 1, 2005
Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated setKarin Janetzko, Jean-Pierre Cazenave, Harald Klüter, et al.
Transfusion|September 28, 2006
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraPaul D Mintz, Anne Neff, Malcolm MacKenzie, et al.
Blood|May 13, 2004
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT TrialJeffrey McCullough, David H Vesole, Richard J Benjamin, et al.
Transfusion|June 24, 2022
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet componentsEdward L Snyder, Allison P Wheeler, Majed Refaai, et al.
Pageof 2